CD58/LFA-3 Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # AF1689J

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Neutralization, Western Blot
Label
Janelia Fluor 646
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human CD58/LFA‑3
Phe29-Arg215
Accession # P19256
Phe29-Arg215
Accession # P19256
Specificity
Detects human CD58/LFA‑3 in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for CD58/LFA-3 Antibody [Janelia Fluor® 646]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD58/LFA-3
Alternate Names
CD58, LFA-3, LFA3
Gene Symbol
CD58
Additional CD58/LFA-3 Products
Product Documents for CD58/LFA-3 Antibody [Janelia Fluor® 646]
Product Specific Notices for CD58/LFA-3 Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...